BACKGROUND: The production of erythropoietin is triggered by impaired oxygen delivery to the kidney, either because of anemia or hypoxemia. High erythropoietin levels have been shown to predict the risk of death among patients with chronic heart failure. We investigated the prognostic value of elevated erythropoietin levels on mortality among very elderly people in the general population. METHODS: The Leiden 85-plus Study is a population-based prospective follow-up study involving 599 people aged 85 years in Leiden, the Netherlands, enrolled between September 1997 and September 1999. Erythropoietin levels were determined at age 86. For this analysis, we included 428 participants with a creatinine clearance of at least 30 mL/min. Mortality data, recorded until Feb. 1, 2008, were obtained from the municipal registry. RESULTS: During follow-up, 324 (75.7%) participants died. Compared with participants whose erythropoietin levels were in the lowest tertile (reference group), those whose levels were in the middle tertile had a 25% increased risk of death (hazard ratio [HR] 1.25, 95% confidence interval [CI] 0.95-1.64), and those whose levels were in the highest tertile had a 73% increased risk (HR 1.73, 95% CI 1.32-2.26) (p value for trend < 0.01). The association between erythropoietin levels and mortality remained largely unchanged after we adjusted for sex, creatinine clearance, hemoglobin level, comorbidity, smoking status and C-reactive protein level, and was similar for deaths from cardiovascular and noncardiovascular causes. INTERPRETATION: Among people aged 85 years and older, elevated erythropoietin levels were associated with an increased risk of death, independent of hemoglobin levels.
BACKGROUND: The production of erythropoietin is triggered by impaired oxygen delivery to the kidney, either because of anemia or hypoxemia. High erythropoietin levels have been shown to predict the risk of death among patients with chronic heart failure. We investigated the prognostic value of elevated erythropoietin levels on mortality among very elderly people in the general population. METHODS: The Leiden 85-plus Study is a population-based prospective follow-up study involving 599 people aged 85 years in Leiden, the Netherlands, enrolled between September 1997 and September 1999. Erythropoietin levels were determined at age 86. For this analysis, we included 428 participants with a creatinine clearance of at least 30 mL/min. Mortality data, recorded until Feb. 1, 2008, were obtained from the municipal registry. RESULTS: During follow-up, 324 (75.7%) participants died. Compared with participants whose erythropoietin levels were in the lowest tertile (reference group), those whose levels were in the middle tertile had a 25% increased risk of death (hazard ratio [HR] 1.25, 95% confidence interval [CI] 0.95-1.64), and those whose levels were in the highest tertile had a 73% increased risk (HR 1.73, 95% CI 1.32-2.26) (p value for trend < 0.01). The association between erythropoietin levels and mortality remained largely unchanged after we adjusted for sex, creatinine clearance, hemoglobin level, comorbidity, smoking status and C-reactive protein level, and was similar for deaths from cardiovascular and noncardiovascular causes. INTERPRETATION: Among people aged 85 years and older, elevated erythropoietin levels were associated with an increased risk of death, independent of hemoglobin levels.
Authors: A Bootsma-van der Wiel; E van Exel; A J M de Craen; J Gussekloo; A M Lagaay; D L Knook; R G J Westendorp Journal: J Clin Epidemiol Date: 2002-11 Impact factor: 6.437
Authors: Peter van der Meer; Adriaan A Voors; Erik Lipsic; Tom D J Smilde; Wiek H van Gilst; Dirk J van Veldhuisen Journal: J Am Coll Cardiol Date: 2004-07-07 Impact factor: 24.094
Authors: Miklos Z Molnar; Adam G Tabak; Ahsan Alam; Maria E Czira; Anna Rudas; Akos Ujszaszi; Gabriella Beko; Marta Novak; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Istvan Mucsi Journal: Clin J Am Soc Nephrol Date: 2011-10-06 Impact factor: 8.237
Authors: Pranav S Garimella; Ronit Katz; Kushang V Patel; Stephen B Kritchevsky; Chirag R Parikh; Joachim H Ix; Linda F Fried; Anne B Newman; Michael G Shlipak; Tamara B Harris; Mark J Sarnak Journal: Circ Heart Fail Date: 2016-01 Impact factor: 8.790
Authors: Michele F Eisenga; Maarten A De Jong; Peter Van der Meer; David E Leaf; Gerwin Huls; Ilja M Nolte; Carlo A J M Gaillard; Stephan J L Bakker; Martin H De Borst Journal: PLoS Med Date: 2019-06-06 Impact factor: 11.069
Authors: Alberto Montesanto; Anna Rita Bonfigli; Maria De Luca; Paolina Crocco; Paolo Garagnani; Elena Marasco; Chiara Pirazzini; Cristina Giuliani; Fabio Romagnoli; Claudio Franceschi; Giuseppe Passarino; Roberto Testa; Fabiola Olivieri; Giuseppina Rose Journal: Sci Rep Date: 2019-07-17 Impact factor: 4.379
Authors: Silvia Mas-Peiro; Philipp C Seppelt; Roberta De Rosa; Marie-Isabel Murray; Jörg Yogarajah; Alexander Berkowitsch; Stephan Fichtlscherer; Andreas M Zeiher; Mariuca Vasa-Nicotera Journal: Front Cardiovasc Med Date: 2020-11-30
Authors: Niels Grote Beverborg; Niek Verweij; Ijsbrand T Klip; Haye H van der Wal; Adriaan A Voors; Dirk J van Veldhuisen; Ron T Gansevoort; Stephan J L Bakker; Pim van der Harst; Peter van der Meer Journal: PLoS One Date: 2015-04-27 Impact factor: 3.240